177 related articles for article (PubMed ID: 23069141)
1. Lack of human tissue-specific correlations for rodent pancreatic and colorectal carcinogens.
Card JW; Fikree H; Haighton LA; Lee-Brotherton V; Wan J; Sangster B
Regul Toxicol Pharmacol; 2012 Dec; 64(3):442-58. PubMed ID: 23069141
[TBL] [Abstract][Full Text] [Related]
2. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans.
Osimitz TG; Droege W; Boobis AR; Lake BG
Food Chem Toxicol; 2013 Oct; 60():550-62. PubMed ID: 23954551
[TBL] [Abstract][Full Text] [Related]
4. The results of assays in Drosophila as indicators of exposure to carcinogens.
Vogel EW; Graf U; Frei HJ; Nivard MM
IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
[TBL] [Abstract][Full Text] [Related]
5. In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis.
Kleinstreuer NC; Dix DJ; Houck KA; Kavlock RJ; Knudsen TB; Martin MT; Paul KB; Reif DM; Crofton KM; Hamilton K; Hunter R; Shah I; Judson RS
Toxicol Sci; 2013 Jan; 131(1):40-55. PubMed ID: 23024176
[TBL] [Abstract][Full Text] [Related]
6. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998.
Gold LS; Manley NB; Slone TH; Rohrbach L; Garfinkel GB
Toxicol Sci; 2005 Jun; 85(2):747-808. PubMed ID: 15800034
[TBL] [Abstract][Full Text] [Related]
7. What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database.
Gold LS; Slone TH; Ames BN
Drug Metab Rev; 1998 May; 30(2):359-404. PubMed ID: 9606609
[TBL] [Abstract][Full Text] [Related]
8. Supplement to the Carcinogenic Potency Database (CPDB): results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology Program in 1995 to 1996.
Gold LS; Manley NB; Slone TH; Rohrbach L
Environ Health Perspect; 1999 Aug; 107 Suppl 4(Suppl 4):527-600. PubMed ID: 10421768
[TBL] [Abstract][Full Text] [Related]
9. Evaluating consistency in the interpretation of NTP rodent cancer bioassays: an examination of mouse lung tumor effects in the 4-MEI study.
Haseman JK
Regul Toxicol Pharmacol; 2013 Jun; 66(1):109-15. PubMed ID: 23545072
[TBL] [Abstract][Full Text] [Related]
10. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
11. Compendium of chemical carcinogens by target organ: results of chronic bioassays in rats, mice, hamsters, dogs, and monkeys.
Gold LS; Manley NB; Slone TH; Ward JM
Toxicol Pathol; 2001; 29(6):639-52. PubMed ID: 11794380
[TBL] [Abstract][Full Text] [Related]
12. Prediction of carcinogenicity from two versus four sex-species groups in the carcinogenic potency database.
Gold LS; Slone TH
J Toxicol Environ Health; 1993 May; 39(1):143-57. PubMed ID: 8492327
[TBL] [Abstract][Full Text] [Related]
13. How useful are chronic (life-span) toxicology studies in rodents in identifying pharmaceuticals that pose a carcinogenic risk to humans?
Monro A
Adverse Drug React Toxicol Rev; 1993; 12(1):5-34. PubMed ID: 8513076
[TBL] [Abstract][Full Text] [Related]
14. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 1/2. A multi-factor ranking scheme for comparing the carcinogenic activity of chemicals.
Nesnow S
Mutat Res; 1990 Sep; 239(2):83-115. PubMed ID: 2385240
[TBL] [Abstract][Full Text] [Related]
15. Computer-aided rodent carcinogenicity prediction.
Lagunin AA; Dearden JC; Filimonov DA; Poroikov VV
Mutat Res; 2005 Oct; 586(2):138-46. PubMed ID: 16112600
[TBL] [Abstract][Full Text] [Related]
16. Carcinogenic chemical-response "fingerprint" for male F344 rats exposed to a series of 195 chemicals: implications for predicting carcinogens with transgenic models.
Johnson FM
Environ Mol Mutagen; 1999; 34(4):234-45. PubMed ID: 10618171
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic carcinogenesis and naturally occurring pancreatic neoplasms of rats and mice in the NCI carcinogenesis testing program.
Milman HA; Ward JM; Chu KC
J Environ Pathol Toxicol; 1978; 1(6):829-40. PubMed ID: 731181
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
19. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
20. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment.
Proctor DM; Gatto NM; Hong SJ; Allamneni KP
Toxicol Sci; 2007 Aug; 98(2):313-26. PubMed ID: 17426108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
